{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:53:30Z","timestamp":1792043610289,"version":"4.4.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fundamental Research Grant Scheme (FRGS), Ministry of Education, Malaysia","award":["FRGS\/1\/2023\/2KK06\/UPM\/03\/01"],"award-info":[{"award-number":["FRGS\/1\/2023\/2KK06\/UPM\/03\/01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10787-024-01607-8","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T09:39:55Z","timestamp":1733391595000},"page":"759-765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Polyphenols mitigating inflammatory mechanisms in inflammatory bowel disease (IBD): focus on the NF-\u0199B and JAK\/STAT pathways"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5695-4477","authenticated-orcid":false,"given":"Elysha Nur","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7518-7365","authenticated-orcid":false,"given":"Noraina","family":"Zakuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8126-3889","authenticated-orcid":false,"given":"Zulkefley","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4386-0348","authenticated-orcid":false,"given":"Sharmili","family":"Vidyadaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4892-6219","authenticated-orcid":false,"given":"Hussin","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6973-0747","authenticated-orcid":false,"given":"Reezal","family":"Ishak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"1607_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1295230","author":"A Alhendi","year":"2023","unstructured":"Alhendi A, Naser SA (2023) The dual role of interleukin-6 in Crohn\u2019s disease pathophysiology. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1295230","journal-title":"Front Immunol"},{"issue":"4","key":"1607_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000336720","volume":"85","author":"T Ali","year":"2012","unstructured":"Ali T, Shakir F, Morton J (2012) Curcumin and inflammatory bowel disease: biological mechanisms and clinical implication. Digestion 85(4):249\u2013255. https:\/\/doi.org\/10.1159\/000336720","journal-title":"Digestion"},{"issue":"9","key":"1607_CR3","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.3390\/MOLECULES27092901","volume":"27","author":"JM Al-Khayri","year":"2022","unstructured":"Al-Khayri JM, Sahana GR, Nagella P, Joseph BV, Alessa FM, Al-Mssallem MQ (2022) Flavonoids as potential anti-inflammatory molecules: a review. Molecules 27(9):2901. https:\/\/doi.org\/10.3390\/MOLECULES27092901","journal-title":"Molecules"},{"issue":"2","key":"1607_CR4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/antiox12020416","volume":"12","author":"S-O Aloo","year":"2023","unstructured":"Aloo S-O, Ofosu FK, Kim N-H, Kilonzi SM, Oh D-H (2023) Insights on dietary polyphenols as agents against metabolic disorders: obesity as a target disease. Antioxidants 12(2):416. https:\/\/doi.org\/10.3390\/antiox12020416","journal-title":"Antioxidants"},{"issue":"10","key":"1607_CR5","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/ueg2.12350","volume":"10","author":"S Aniwan","year":"2022","unstructured":"Aniwan S, Santiago P, Loftus EV, Park SH (2022) The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. U Eur Gastroenterol J 10(10):1063\u20131076. https:\/\/doi.org\/10.1002\/ueg2.12350","journal-title":"U Eur Gastroenterol J"},{"key":"1607_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.794169","author":"Q-Y Ban","year":"2022","unstructured":"Ban Q-Y, Liu M, Ding N, Chen Y, Lin Q, Zha J-M, He W-Q (2022) Nutraceuticals for the treatment of IBD: current progress and future directions. Front Nutr. https:\/\/doi.org\/10.3389\/fnut.2022.794169","journal-title":"Front Nutr"},{"issue":"5","key":"1607_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/S41573-023-00670-0","volume":"22","author":"TH Baryakova","year":"2023","unstructured":"Baryakova TH, Pogostin BH, Langer R, McHugh KJ (2023) Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Discovery 22(5):387. https:\/\/doi.org\/10.1038\/S41573-023-00670-0","journal-title":"Nat Rev Drug Discovery"},{"issue":"6","key":"1607_CR8","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/cells9061451","volume":"9","author":"S Bose","year":"2020","unstructured":"Bose S, Banerjee S, Mondal A, Chakraborty U, Pumarol J, Croley CR, Bishayee A (2020) Targeting the JAK\/STAT signaling pathway using phytocompounds for cancer prevention and therapy. Cells 9(6):1451. https:\/\/doi.org\/10.3390\/cells9061451","journal-title":"Cells"},{"issue":"2","key":"1607_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/J.CROHNS.2011.08.012\/2\/6-2-FIG043.JPEG","volume":"6","author":"M Br\u00fcckner","year":"2012","unstructured":"Br\u00fcckner M, Westphal S, Domschke W, Kucharzik T, L\u00fcgering A (2012) Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis. J Crohn\u2019s Colitis 6(2):226\u2013235. https:\/\/doi.org\/10.1016\/J.CROHNS.2011.08.012\/2\/6-2-FIG043.JPEG","journal-title":"J Crohn\u2019s Colitis"},{"issue":"4","key":"1607_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/J.CROHNS.2013.01.010","volume":"7","author":"J Burisch","year":"2013","unstructured":"Burisch J, Jess T, Martinato M, Lakatos PL (2013) The burden of inflammatory bowel disease in Europe. J Crohn\u2019s Colitis 7(4):322\u2013337. https:\/\/doi.org\/10.1016\/J.CROHNS.2013.01.010","journal-title":"J Crohn\u2019s Colitis"},{"key":"1607_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/FMED.2021.765474\/FULL","volume":"8","author":"Z Cai","year":"2021","unstructured":"Cai Z, Wang S, Li J (2021) Treatment of inflammatory bowel disease: a comprehensive review. Front Med 8:765474. https:\/\/doi.org\/10.3389\/FMED.2021.765474\/FULL","journal-title":"Front Med"},{"issue":"4","key":"1607_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/S44197-023-00145-W","volume":"13","author":"X Chen","year":"2023","unstructured":"Chen X, Xiang X, Xia W, Li X, Wang S, Ye S, Tian L, Zhao L, Ai F, Shen Z, Nie K, Deng M, Wang X (2023) Evolving trends and burden of inflammatory bowel disease in Asia, 1990\u20132019: a comprehensive analysis based on the global burden of disease study. J Epidemiol Global Health 13(4):725. https:\/\/doi.org\/10.1007\/S44197-023-00145-W","journal-title":"J Epidemiol Global Health"},{"issue":"2","key":"1607_CR13","first-page":"86","volume":"73","author":"PPB Cheong","year":"2018","unstructured":"Cheong PPB, Siang NY, Sidhu J, Kok M (2018) Epidemiology of inflammatory bowel disease in southern peninsular Malaysia. Med J Malays 73(2):86\u201389","journal-title":"Med J Malays"},{"issue":"1","key":"1607_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/molecules25010063","volume":"25","author":"E Cione","year":"2019","unstructured":"Cione E, La Torre C, Cannataro R, Caroleo MC, Plastina P, Gallelli L (2019) Quercetin, epigallocatechin gallate, curcumin, and resveratrol: from dietary sources to human MicroRNA modulation. Molecules 25(1):63. https:\/\/doi.org\/10.3390\/molecules25010063","journal-title":"Molecules"},{"issue":"28","key":"1607_CR15","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.3748\/WJG.V26.I28.4055","volume":"26","author":"F Cordes","year":"2020","unstructured":"Cordes F, Foell D, Ding JN, Varga G, Bettenworth D (2020) Differential regulation of JAK\/STAT-signaling in patients with ulcerative colitis and Crohn\u2019s disease. World J Gastroenterol 26(28):4055. https:\/\/doi.org\/10.3748\/WJG.V26.I28.4055","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1607_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/S40744-015-0015-X","volume":"2","author":"NM Engel-Nitz","year":"2015","unstructured":"Engel-Nitz NM, Ogale S, Kulakodlu M (2015) Use of anti-tumor necrosis factor therapy: a retrospective study of monotherapy and adherence to combination therapy with non-biologic disease-modifying anti-rheumatic drugs. Rheumatol Ther 2(2):127. https:\/\/doi.org\/10.1007\/S40744-015-0015-X","journal-title":"Rheumatol Ther"},{"issue":"3","key":"1607_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/MOLECULES22030484","volume":"22","author":"FY Fan","year":"2017","unstructured":"Fan FY, Sang LX, Jiang M, McPhee DJ (2017a) Catechins and their therapeutic benefits to inflammatory bowel disease. Molecules 22(3):484. https:\/\/doi.org\/10.3390\/MOLECULES22030484","journal-title":"Molecules"},{"issue":"3","key":"1607_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/molecules22030484","volume":"22","author":"F-Y Fan","year":"2017","unstructured":"Fan F-Y, Sang L-X, Jiang M (2017b) Catechins and their therapeutic benefits to inflammatory bowel disease. Molecules 22(3):484. https:\/\/doi.org\/10.3390\/molecules22030484","journal-title":"Molecules"},{"key":"1607_CR19","doi-asserted-by":"publisher","first-page":"1360065","DOI":"10.3389\/FIMMU.2024.1360065\/BIBTEX","volume":"15","author":"C Ferreira","year":"2024","unstructured":"Ferreira C, Vieira P, S\u00e1 H, Malva J, Castelo-Branco M, Reis F, Viana S (2024) Polyphenols: immunonutrients tipping the balance of immunometabolism in chronic diseases. Front Immunol 15:1360065. https:\/\/doi.org\/10.3389\/FIMMU.2024.1360065\/BIBTEX","journal-title":"Front Immunol"},{"issue":"4","key":"1607_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/mi.2012.24","volume":"5","author":"BM Fournier","year":"2012","unstructured":"Fournier BM, Parkos CA (2012) The role of neutrophils during intestinal inflammation. Mucosal Immunol 5(4):354\u2013366. https:\/\/doi.org\/10.1038\/mi.2012.24","journal-title":"Mucosal Immunol"},{"issue":"3","key":"1607_CR21","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.3390\/ijms24032696","volume":"24","author":"R Gomez-Bris","year":"2023","unstructured":"Gomez-Bris R, Saez A, Herrero-Fernandez B, Rius C, Sanchez-Martinez H, Gonzalez-Granado JM (2023) CD4 T-cell subsets and the pathophysiology of inflammatory bowel disease. Int J Mol Sci 24(3):2696. https:\/\/doi.org\/10.3390\/ijms24032696","journal-title":"Int J Mol Sci"},{"key":"1607_CR22","doi-asserted-by":"publisher","first-page":"1411566","DOI":"10.3389\/FPHAR.2024.1411566\/FULL","volume":"15","author":"Y Gu","year":"2024","unstructured":"Gu Y, Lou Y, Zhou Z, Zhao X, Ye X, Wu S, Li H, Ji Y (2024) Resveratrol for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis. Front Pharmacol 15:1411566. https:\/\/doi.org\/10.3389\/FPHAR.2024.1411566\/FULL","journal-title":"Front Pharmacol"},{"issue":"1","key":"1607_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, Zeng C, Zhou T, Zhang J (2024a) NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther 9(1):53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1607_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, Zeng C, Zhou T, Zhang J (2024b) NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther 9(1):1\u201337. https:\/\/doi.org\/10.1038\/s41392-024-01757-9","journal-title":"Signal Transduct Target Ther"},{"key":"1607_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.625423","author":"X Han","year":"2021","unstructured":"Han X, Ding S, Jiang H, Liu G (2021) Roles of macrophages in the development and treatment of gut inflammation. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.625423","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"1607_CR26","doi-asserted-by":"publisher","first-page":"9183","DOI":"10.3390\/molecules20059183","volume":"20","author":"Y He","year":"2015","unstructured":"He Y, Yue Y, Zheng X, Zhang K, Chen S, Du Z (2015) Curcumin, inflammation, and chronic diseases: How are they linked? Molecules 20(5):9183\u20139213. https:\/\/doi.org\/10.3390\/molecules20059183","journal-title":"Molecules"},{"issue":"5","key":"1607_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/ECCO-JCC\/JJV039","volume":"9","author":"I Hilmi","year":"2015","unstructured":"Hilmi I, Jaya F, Chua A, Heng WC, Singh H, Goh KL (2015) A first study on the incidence and prevalence of IBD in Malaysia\u2014results from the Kinta Valley IBD epidemiology study. J Crohn\u2019s Colitis 9(5):404\u2013409. https:\/\/doi.org\/10.1093\/ECCO-JCC\/JJV039","journal-title":"J Crohn\u2019s Colitis"},{"issue":"1","key":"1607_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6(1):1\u201333. https:\/\/doi.org\/10.1038\/s41392-021-00791-1","journal-title":"Signal Transduct Target Ther"},{"key":"1607_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.crfs.2023.100521","volume":"6","author":"PE Jamieson","year":"2023","unstructured":"Jamieson PE, Carbonero F, Stevens JF (2023) Dietary (poly)phenols mitigate inflammatory bowel disease: Therapeutic targets, mechanisms of action, and clinical observations. Curr Res Food Sci 6:100521. https:\/\/doi.org\/10.1016\/j.crfs.2023.100521","journal-title":"Curr Res Food Sci"},{"key":"1607_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/J.BBACLI.2015.11.002","volume":"5","author":"A Jurjus","year":"2016","unstructured":"Jurjus A, Eid A, Al Kattar S, Zeenny MN, Gerges-Geagea A, Haydar H, Hilal A, Oueidat D, Matar M, Tawilah J, Hussein IH, Schembri-Wismayer P, Cappello F, Tomasello G, Leone A, Jurjus RA (2016) Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: the links. BBA Clin 5:16\u201324. https:\/\/doi.org\/10.1016\/J.BBACLI.2015.11.002","journal-title":"BBA Clin"},{"key":"1607_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/FMED.2022.865131\/BIBTEX","volume":"9","author":"SM Khoramjoo","year":"2022","unstructured":"Khoramjoo SM, Kazemifard N, Baradaran Ghavami S, Farmani M, Shahrokh S, Asadzadeh Aghdaei H, Sherkat G, Zali MR (2022) Overview of three proliferation pathways (Wnt, Notch, and Hippo) in intestine and immune system and their role in inflammatory bowel diseases (IBDs). Front Med 9:865131. https:\/\/doi.org\/10.3389\/FMED.2022.865131\/BIBTEX","journal-title":"Front Med"},{"issue":"1","key":"1607_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4110\/IN.2017.17.1.25","volume":"17","author":"DH Kim","year":"2017","unstructured":"Kim DH, Cheon JH (2017) Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies. Immune Netw 17(1):25\u201340. https:\/\/doi.org\/10.4110\/IN.2017.17.1.25","journal-title":"Immune Netw"},{"key":"1607_CR33","doi-asserted-by":"publisher","first-page":"263947","DOI":"10.3389\/FPHAR.2017.00460\/BIBTEX","volume":"8","author":"P Li","year":"2017","unstructured":"Li P, Zheng Y, Chen X (2017) Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics. Front Pharmacol 8:263947. https:\/\/doi.org\/10.3389\/FPHAR.2017.00460\/BIBTEX","journal-title":"Front Pharmacol"},{"key":"1607_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106812","volume":"193","author":"W Liu","year":"2023","unstructured":"Liu W, Cui X, Zhong Y, Ma R, Liu B, Xia Y (2023) Phenolic metabolites as therapeutic in inflammation and neoplasms: molecular pathways explaining their efficacy. Pharmacol Res 193:106812. https:\/\/doi.org\/10.1016\/j.phrs.2023.106812","journal-title":"Pharmacol Res"},{"issue":"20","key":"1607_CR35","doi-asserted-by":"publisher","first-page":"11076","DOI":"10.3390\/IJMS222011076","volume":"22","author":"Z Ma","year":"2021","unstructured":"Ma Z, Du B, Li J, Yang Y, Zhu F (2021) An Insight into anti-inflammatory activities and inflammation related diseases of anthocyanins: a review of both in vivo and in vitro investigations. Int J Mol Sci 22(20):11076. https:\/\/doi.org\/10.3390\/IJMS222011076","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1607_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/ANTIOX9010035","volume":"9","author":"T Magrone","year":"2019","unstructured":"Magrone T, Magrone M, Russo MA, Jirillo E (2019a) Recent advances on the anti-inflammatory and antioxidant properties of red grape polyphenols: in vitro and in vivo studies. Antioxidants 9(1):35. https:\/\/doi.org\/10.3390\/ANTIOX9010035","journal-title":"Antioxidants"},{"issue":"4","key":"1607_CR37","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.7150\/ijbs.90982","volume":"20","author":"AA Mamun","year":"2024","unstructured":"Mamun AA, Shao C, Geng P, Wang S, Xiao J (2024) Polyphenols targeting NF-\u03baB pathway in neurological disorders: What we know so far? Int J Biol Sci 20(4):1332\u20131355. https:\/\/doi.org\/10.7150\/ijbs.90982","journal-title":"Int J Biol Sci"},{"key":"1607_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/FMED.2022.897936\/BIBTEX","volume":"9","author":"J Marsal","year":"2022","unstructured":"Marsal J, Barreiro-de Acosta M, Blumenstein I, Cappello M, Bazin T, Sebastian S (2022) Management of non-response and loss of response to anti-tumor necrosis factor therapy in inflammatory bowel disease. Front Med 9:897936. https:\/\/doi.org\/10.3389\/FMED.2022.897936\/BIBTEX","journal-title":"Front Med"},{"key":"1607_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES26010229","author":"T Meng","year":"2021","unstructured":"Meng T, Xiao D, Muhammed A, Deng J, Chen L, He J (2021) Anti-inflammatory action and mechanisms of resveratrol. Molecules. https:\/\/doi.org\/10.3390\/MOLECULES26010229","journal-title":"Molecules"},{"issue":"S4","key":"1607_CR40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s12889-019-6858-2","volume":"19","author":"NM Mokhtar","year":"2019","unstructured":"Mokhtar NM, Nawawi KNM, Verasingam J, Zhiqin W, Sagap I, Azman ZAM, Mazlan L, Hamid HA, Yaacob NY, Rose IM, Den ELN, Wan MS, Raja Ali RA (2019) A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia. BMC Public Health 19(S4):550. https:\/\/doi.org\/10.1186\/s12889-019-6858-2","journal-title":"BMC Public Health"},{"key":"1607_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS24010340","author":"D Mokra","year":"2023","unstructured":"Mokra D, Joskova M, Mokry J (2023) Therapeutic effects of green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) in relation to molecular pathways controlling inflammation, oxidative stress, and apoptosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS24010340","journal-title":"Int J Mol Sci"},{"key":"1607_CR42","doi-asserted-by":"publisher","DOI":"10.1053\/J.GASTRO.2011.10.001","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. https:\/\/doi.org\/10.1053\/J.GASTRO.2011.10.001","journal-title":"Gastroenterology"},{"issue":"1","key":"1607_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1165\/RCMB.2012-0525OC\/SUPPL_FILE\/DISCLOSURES.PDF","volume":"50","author":"APT Monteiro","year":"2014","unstructured":"Monteiro APT, Soledade E, Pinheiro CS, Dellatorre-Teixeira L, Oliveira GP, Oliveira MG, Peters-Golden M, Rocco PRM, Benjamim CF, Canetti C (2014) Pivotal role of the 5-lipoxygenase pathway in lung injury after experimental sepsis. Am J Respir Cell Mol Biol 50(1):87\u201395. https:\/\/doi.org\/10.1165\/RCMB.2012-0525OC\/SUPPL_FILE\/DISCLOSURES.PDF","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"1607_CR44","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.3390\/molecules26092824","volume":"26","author":"SY Moon","year":"2021","unstructured":"Moon SY, Kim KD, Yoo J, Lee J-H, Hwangbo C (2021) Phytochemicals targeting JAK\u2013stat pathways in inflammatory bowel disease: insights from animal models. Molecules 26(9):2824. https:\/\/doi.org\/10.3390\/molecules26092824","journal-title":"Molecules"},{"issue":"6","key":"1607_CR45","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.anai.2023.01.010","volume":"130","author":"SS Mustafa","year":"2023","unstructured":"Mustafa SS (2023) Steroid-induced secondary immune deficiency. Ann Allergy Asthma Immunol 130(6):713\u2013717. https:\/\/doi.org\/10.1016\/j.anai.2023.01.010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"1607_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S12328-017-0813-5","volume":"11","author":"A Nishida","year":"2017","unstructured":"Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A (2017) Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol 11(1):1\u201310. https:\/\/doi.org\/10.1007\/S12328-017-0813-5","journal-title":"Clin J Gastroenterol"},{"key":"1607_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS21072299","author":"MA Panaro","year":"2020","unstructured":"Panaro MA, Corrado A, Benameur T, Paolo CF, Cici D, Porro C (2020) The emerging role of curcumin in the modulation of TLR-4 signaling pathway: focus on neuroprotective and anti-rheumatic properties. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS21072299","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1607_CR48","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3904\/KJIM.2022.132","volume":"37","author":"J Park","year":"2022","unstructured":"Park J, Cheon JH (2022) Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-\u03b1. Korean J Intern Med 37(5):895. https:\/\/doi.org\/10.3904\/KJIM.2022.132","journal-title":"Korean J Intern Med"},{"issue":"1","key":"1607_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3748\/WJG.V20.I1.64","volume":"20","author":"J Pedersen","year":"2014","unstructured":"Pedersen J, Coskun M, Soendergaard C, Salem M, Nielsen OH (2014) Inflammatory pathways of importance for management of inflammatory bowel disease. World J Gastroenterol: WJG 20(1):64. https:\/\/doi.org\/10.3748\/WJG.V20.I1.64","journal-title":"World J Gastroenterol: WJG"},{"issue":"6","key":"1607_CR50","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/md21060323","volume":"21","author":"L Pereira","year":"2023","unstructured":"Pereira L, Cotas J (2023) Therapeutic potential of polyphenols and other micronutrients of marine origin. Mar Drugs 21(6):323. https:\/\/doi.org\/10.3390\/md21060323","journal-title":"Mar Drugs"},{"key":"1607_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHRS.2024.107086","volume":"201","author":"M Puccetti","year":"2024","unstructured":"Puccetti M, Pariano M, Schoubben A, Giovagnoli S, Ricci M (2024) Biologics, theranostics, and personalized medicine in drug delivery systems. Pharmacol Res 201:107086. https:\/\/doi.org\/10.1016\/J.PHRS.2024.107086","journal-title":"Pharmacol Res"},{"key":"1607_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021526","author":"A Saez","year":"2023","unstructured":"Saez A, Herrero-Fernandez B, Gomez-Bris R, S\u00e1nchez-Martinez H, Gonzalez-Granado JM (2023) Pathophysiology of inflammatory bowel disease: innate immune system. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24021526","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1607_CR53","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.3390\/IJMS23073464","volume":"23","author":"PT Santana","year":"2022","unstructured":"Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP (2022) Dysbiosis in inflammatory bowel disease: pathogenic role and potential therapeutic targets. Int J Mol Sci 23(7):3464. https:\/\/doi.org\/10.3390\/IJMS23073464","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1607_CR54","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/hep.27982","volume":"62","author":"KM Schneider","year":"2015","unstructured":"Schneider KM, Bieghs V, Heymann F, Hu W, Dreymueller D, Liao L, Frissen M, Ludwig A, Gassler N, Pabst O, Latz E, Sellge G, Penders J, Tacke F, Trautwein C (2015) CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: limiting steatohepatitis by maintaining intestinal homeostasis. Hepatology 62(5):1405\u20131416. https:\/\/doi.org\/10.1002\/hep.27982","journal-title":"Hepatology"},{"issue":"3","key":"1607_CR55","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/NU13030728","volume":"13","author":"H Shakoor","year":"2021","unstructured":"Shakoor H, Feehan J, Apostolopoulos V, Platat C, Al Dhaheri AS, Ali HI, Ismail LC, Bosevski M, Stojanovska L (2021) Immunomodulatory effects of dietary polyphenols. Nutrients 13(3):728. https:\/\/doi.org\/10.3390\/NU13030728","journal-title":"Nutrients"},{"issue":"3","key":"1607_CR56","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/gut.2006.094599","volume":"56","author":"H Shapiro","year":"2007","unstructured":"Shapiro H, Singer P, Halpern Z, Bruck R (2007) Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis. Gut 56(3):426\u2013436. https:\/\/doi.org\/10.1136\/gut.2006.094599","journal-title":"Gut"},{"issue":"6","key":"1607_CR57","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/APT.15097","volume":"49","author":"UN Shivaji","year":"2019","unstructured":"Shivaji UN, Sharratt CL, Thomas T, Smith SCL, Iacucci M, Moran GW, Ghosh S, Bhala N (2019) Review article: managing the adverse events caused by anti-TNF therapy in inflammatory bowel disease. Aliment Pharmacol Ther 49(6):664\u2013680. https:\/\/doi.org\/10.1111\/APT.15097","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"1607_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ANTIOX9080669","volume":"9","author":"A Singh","year":"2020","unstructured":"Singh A, Yau YF, Leung KS, El-Nezami H, Lee JCY (2020) Interaction of polyphenols as antioxidant and anti-inflammatory compounds in brain\u2013liver\u2013gut axis. Antioxidants 9(8):1\u201320. https:\/\/doi.org\/10.3390\/ANTIOX9080669","journal-title":"Antioxidants"},{"issue":"4","key":"1607_CR59","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/med.21306","volume":"34","author":"M Singh Bahia","year":"2014","unstructured":"Singh Bahia M, Kumar Katare Y, Silakari O, Vyas B, Silakari P (2014) Inhibitors of microsomal prostaglandin E2 synthase-1 enzyme as emerging anti-inflammatory candidates. Med Res Rev 34(4):825\u2013855. https:\/\/doi.org\/10.1002\/med.21306","journal-title":"Med Res Rev"},{"issue":"9","key":"1607_CR60","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/MOLECULES21091263","volume":"21","author":"E Tili","year":"2016","unstructured":"Tili E, Michaille JJ (2016) Promiscuous effects of some phenolic natural products on inflammation at least in part arise from their ability to modulate the expression of global regulators, Namely microRNAs. Molecules 21(9):1263. https:\/\/doi.org\/10.3390\/MOLECULES21091263","journal-title":"Molecules"},{"key":"1607_CR61","doi-asserted-by":"publisher","DOI":"10.5772\/25592","author":"CD Tran","year":"2012","unstructured":"Tran CD, Katsikeros R, Abimosleh SM, Tran CD, Katsikeros R, Abimosleh SM (2012) Current and novel treatments for ulcerative colitis. Ulcerative Colitis Genet Compl. https:\/\/doi.org\/10.5772\/25592","journal-title":"Ulcerative Colitis Genet Compl"},{"issue":"12","key":"1607_CR62","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/RHEUMATOLOGY\/39.12.1383","volume":"39","author":"TP Van Staa","year":"2000","unstructured":"Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology 39(12):1383\u20131389. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/39.12.1383","journal-title":"Rheumatology"},{"issue":"12","key":"1607_CR63","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.3390\/biomedicines11123229","volume":"11","author":"M Vebr","year":"2023","unstructured":"Vebr M, Pomaha\u010dov\u00e1 R, S\u00fdkora J, Schwarz J (2023) A narrative review of cytokine networks: pathophysiological and therapeutic implications for inflammatory bowel disease pathogenesis. Biomedicines 11(12):3229. https:\/\/doi.org\/10.3390\/biomedicines11123229","journal-title":"Biomedicines"},{"issue":"1","key":"1607_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, Hu J, Fleming I, Wang DW (2021) Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther 6(1):1\u201330. https:\/\/doi.org\/10.1038\/s41392-020-00443-w","journal-title":"Signal Transduct Target Ther"},{"key":"1607_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOPHA.2024.117302","volume":"179","author":"X Wang","year":"2024","unstructured":"Wang X, Peng J, Cai P, Xia Y, Yi C, Shang A, Akanyibah FA, Mao F (2024) The emerging role of the gut microbiota and its application in inflammatory bowel disease. Biomed Pharmacother 179:117302. https:\/\/doi.org\/10.1016\/J.BIOPHA.2024.117302","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1607_CR66","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4187\/respcare.06314","volume":"63","author":"DM Williams","year":"2018","unstructured":"Williams DM (2018) Clinical pharmacology of corticosteroids. Respir Care 63(6):655\u2013670. https:\/\/doi.org\/10.4187\/respcare.06314","journal-title":"Respir Care"},{"key":"1607_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/NU10111618","author":"N Yahfoufi","year":"2018","unstructured":"Yahfoufi N, Alsadi N, Jambi M, Matar C (2018a) The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients. https:\/\/doi.org\/10.3390\/NU10111618","journal-title":"Nutrients"},{"issue":"11","key":"1607_CR68","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/NU10111618","volume":"10","author":"N Yahfoufi","year":"2018","unstructured":"Yahfoufi N, Alsadi N, Jambi M, Matar C (2018b) The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients 10(11):1618. https:\/\/doi.org\/10.3390\/NU10111618","journal-title":"Nutrients"},{"key":"1607_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/J.TAAP.2024.116882","volume":"484","author":"Z Yaqin","year":"2024","unstructured":"Yaqin Z, Kehan W, Yi Z, Naijian W, Wei Q, Fei M (2024) Resveratrol alleviates inflammatory bowel disease by inhibiting JAK2\/STAT3 pathway activity via the reduction of O-GlcNAcylation of STAT3 in intestinal epithelial cells. Toxicol Appl Pharmacol 484:116882. https:\/\/doi.org\/10.1016\/J.TAAP.2024.116882","journal-title":"Toxicol Appl Pharmacol"},{"key":"1607_CR70","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semcancer.2016.02.001","volume":"40\u201341","author":"NS Yarla","year":"2016","unstructured":"Yarla NS, Bishayee A, Sethi G, Reddanna P, Kalle AM, Dhananjaya BL, Dowluru KSVGK, Chintala R, Duddukuri GR (2016) Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. Semin Cancer Biol 40\u201341:48\u201381. https:\/\/doi.org\/10.1016\/j.semcancer.2016.02.001","journal-title":"Semin Cancer Biol"},{"key":"1607_CR71","unstructured":"Yasir M, Goyal A, Sonthalia S (2023) Corticosteroid adverse effects. StatPearls. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK531462\/"},{"issue":"12","key":"1607_CR72","first-page":"22529","volume":"8","author":"Y Ye","year":"2015","unstructured":"Ye Y, Pang Z, Chen W, Ju S, Zhou C (2015) The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med 8(12):22529","journal-title":"Int J Clin Exp Med"},{"key":"1607_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.716672","author":"Q Yin","year":"2021","unstructured":"Yin Q, Wang L, Yu H, Chen D, Zhu W, Sun C (2021) Pharmacological effects of polyphenol phytochemicals on the JAK-STAT signaling pathway. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.716672","journal-title":"Front Pharmacol"},{"issue":"13","key":"1607_CR74","doi-asserted-by":"publisher","first-page":"6939","DOI":"10.3390\/ijms23136939","volume":"23","author":"C Yu","year":"2022","unstructured":"Yu C, Wang D, Yang Z, Wang T (2022) Pharmacological effects of polyphenol phytochemicals on the intestinal inflammation via targeting TLR4\/NF-\u03baB signaling pathway. Int J Mol Sci 23(13):6939. https:\/\/doi.org\/10.3390\/ijms23136939","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1607_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z, Zhang H, Hu H (2020) Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther 5(1):1\u201323. https:\/\/doi.org\/10.1038\/s41392-020-00312-6","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"1607_CR76","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.3748\/WJG.V20.I12.3146","volume":"20","author":"T Zenlea","year":"2014","unstructured":"Zenlea T, Peppercorn MA (2014) Immunosuppressive therapies for inflammatory bowel disease. World J Gastroenterol: WJG 20(12):3146. https:\/\/doi.org\/10.3748\/WJG.V20.I12.3146","journal-title":"World J Gastroenterol: WJG"},{"key":"1607_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES28010146\/S1","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Wen F, Sun F, Xu Z, Liu Y, Tao C, Sun F, Jiang M, Yang M, Yao J (2023) Efficacy and mechanism of quercetin in the treatment of experimental colitis using network pharmacology analysis. Molecules. https:\/\/doi.org\/10.3390\/MOLECULES28010146\/S1","journal-title":"Molecules"},{"issue":"1","key":"1607_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-11-59\/FIGURES\/8","volume":"11","author":"HT Zhu","year":"2014","unstructured":"Zhu HT, Bian C, Yuan JC, Chu WH, Xiang X, Chen F, Wang CS, Feng H, Lin JK (2014) Curcumin attenuates acute inflammatory injury by inhibiting the TLR4\/MyD88\/NF-\u03baB signaling pathway in experimental traumatic brain injury. J Neuroinflammation 11(1):1\u201317. https:\/\/doi.org\/10.1186\/1742-2094-11-59\/FIGURES\/8","journal-title":"J Neuroinflammation"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01607-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01607-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01607-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:06:14Z","timestamp":1740107174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01607-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1607"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01607-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}